Evidence map›Paper›PMID 19630531›Full record

ArticleRadiation research2009

Radiation nephropathy is not mitigated by antagonists of oxidative stress.

Eric P Cohen, Brian L Fish, Amy A Irving, Mohan M Rajapurkar, Sudhir V Shah, John E Moulder

Abstract read
In one paragraph

Article in Radiation research, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Salen Mn complexes mitigate radiation injury in normal tissues.Anti-cancer agents in medicinal chemistry · 2011
    Review
  9. Review
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Eric P CohenDepartments of Medicine and, Medical College of Wisconsin, Milwaukee, Wisconsin, 53226, USA.
Brian L Fish
Amy A Irving
Mohan M Rajapurkar
Sudhir V Shah
John E Moulder
Medical College of Wisconsin · USMuljibhai Patel Urological Hospital · INUniversity of Arkansas for Medical Sciences · US

Funding

Training and educationU19AI067734 · NIAID · MEDICAL COLLEGE OF WISCONSIN · PI MOULDER, JOHN E · 2005 to 2009
$18.2M
KIDNEY RESPONSE TO RADIATION AND CHEMOTHERAPYR01CA024652 · NCI · MEDICAL COLLEGE OF WISCONSIN · PI MOULDER, JOHN E · 1985 to 2006
$1.8M
NCI NIH HHS CA24652NCI NIH HHS R01 CA024652NIAAA NIH HHS AA067734NIAID NIH HHS U19 AI067734
6 · The paper itself

Abstract

Abstract Persistent, chronic oxidative injury may play a mechanistic role in late radiation injury. Thus antioxidants may be useful as mitigators of radiation injury. The antioxidants deferiprone, genistein and apocynin were tested in a rat radiation nephropathy model that uses single-fraction total-body irradiation (TBI) followed by syngeneic bone marrow transplant. Deferiprone was added to the drinking water at 1.0 or 2.5 g/liter, starting 3 days after the TBI. Urinary bleomycin-detectable iron, which could enhance production of oxygen radicals, was reduced in the rats on deferiprone compared to untreated rats, but deferiprone did not mitigate radiation nephropathy. Genistein added to the chow at 750 mg/kg starting immediately after TBI did not mitigate radiation nephropathy. Apocynin added to the drinking water at 250 mg/liter immediately after TBI did not mitigate radiation nephropathy. Thus three different types of antioxidants, when used at doses consistent with an antioxidant effect, had no mitigation efficacy against radiation nephropathy.

Indexed as

AnimalsAntioxidantsDose-Response Relationship, RadiationKidney DiseasesMaleOxidative StressRadiation DosageRadiation InjuriesRadiation-Protective AgentsRadiation ToleranceRatsTreatment OutcomeWhole-Body IrradiationAntioxidantsRadiation-Protective Agents

Identifiers

PMID19630531
PMCPMC2727918
OpenAlexW2035919283

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.